35 year old male patient self injecting using a Risankizumab (trade name Skyrizi) pen. Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23A) and blocks the activity of pro-inflammatory cytokines. It is used to treat moderate to severe plaque psoriasis and active psoriatic arthritis. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 6048 px × 4024 px |
Modell-Rechte: | vorhanden |
Restrictions: |
|